Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable 3-36 (IGHV3-36) is a gene segment within the immunoglobulin heavy chain variable (IGHV) region located on chromosome 14. It encodes the variable domain portion of the heavy chain in antibodies, which pairs with light chain variable regions to form the antigen-binding site of immunoglobulins. IGHV gene segments, including IGHV3-36, are assembled by V(D)J recombination in developing B cells, producing immense diversity in the antibody repertoire that is essential for adaptive immunity[3][5]. When present in functional B-cell receptors or secreted antibodies, the protein product enables precise antigen recognition. IGHV3-36 itself is not a direct drug target, but its gene usage can influence antibody specificity, affinity, and may be studied for its role in immune repertoire diversity, infectious disease response, or B-cell malignancies[4][5]. Note: IGHV3-36 is sometimes annotated as a pseudogene in certain genome builds, meaning that in some individuals or reference sequences it may not encode a functional V segment[1]. However, the IGHV gene family overall is vital for immune function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 3-36 (IGHV3-36).